MILPITAS, Calif., April 29, 2014 (GLOBE NEWSWIRE) -- Nanometrics Incorporated (Nasdaq: NANO ), a leading provider of advanced process control metrology and inspection systems, today announced financial results for its first quarter ended March 29, 2014.
First quarter Highlights
- Record IMPULSE ® Integrated Metrology revenues for Optical Critical Dimension (OCD) process control in high-volume foundry applications;
- Record UniFire ® revenues, with follow-on shipments for high-volume manufacturing in advanced 3D packaging and new customer acceptance for data storage;
- New qualifications of Atlas ® systems for OCD process control for advanced 14nm and early 10nm process development for FinFET logic devices; and
- Delivery of a SPARK™ advanced macro inspection system for rapid screening and characterization of defects for advanced litho cluster control.
| GAAP Results | |||
| Q1 2014 | Q4 2013 | Q1 2013 | |
| Revenues | $ 51,576 | $ 46,159 | $ 24,552 |
| Gross Profit | $ 24,149 | $ 21,909 | $ 10,486 |
| Income (Loss) from Operations | $ 2,016 | $ 1,292 | $ (9,603) |
| Net Income (Loss) | $ 1,595 | $ 556 | $ (5,582) |
| Earnings (Loss) per Diluted Share | $ 0.07 | $ 0.02 | $ (0.24) |
| Non-GAAP Results | |||
| Q1 2014 | Q4 2013 | Q1 2013 | |
| Gross Profit | $ 24,823 | $ 22,579 | $ 11,144 |
| Income (Loss) from Operations | $ 2,798 | $ 2,075 | $ (8,747) |
| Net Income (Loss) | $ 2,095 | $ 1,022 | $ (5,032) |
| Earnings (Loss) per Diluted Share | $ 0.09 | $ 0.04 | $ (0.22) |
| A reconciliation between GAAP operating results and non-GAAP operating results is provided following the financial statements that are part of this release and on the investor page of our website. Non-GAAP results for all periods presented exclude the impact of amortization of acquired intangible assets and certain discrete tax items. |
Commenting on the company's results, president and chief executive officer Dr. Timothy J. Stultz said, "First quarter revenues came in largely as expected, with earnings per share exceeding expectations at this revenue level. In the first quarter, our revenue growth primarily reflected significant OCD spending for 3D NAND and continued traction for our UniFire product line -- in both the advanced 3D packaging market as well as front-end adoption in the data storage market. As we look to the second quarter, we are seeing a considerable shift in the composition of our revenues, with NAND taking a pause, DRAM strengthening and logic revenues improving. Notably, in the second quarter we forecast a potential new record for our foundry business, and expect to achieve a more balanced mix of revenues among the top four semiconductor spenders than we have experienced at any time in our history. This outlook reflects the dynamic nature of industry spending patterns while also highlighting our market share gains and increasing penetration into pure-play foundries -- both of which are core strategic objectives for Nanometrics.
"As we look beyond the first half, recent reports by our customers and industry analysts suggest that the ramp in leading-edge 16nm FinFET foundry spending and additional deployments of 3D NAND capacity may be delayed into early 2015. While any such delays would impact a portion of our business pipeline for the second half, we continue to see a very strong growth year for Nanometrics in 2014, and are encouraged by continued technology investments by the world's leading semiconductor companies contributing to a positive outlook for 2015 as well."
First Quarter 2014 Summary
Revenues for the first quarter of 2014 were $51.6 million, up 12% from $46.2 million in the fourth quarter of 2013 and up 110% from $24.6 million in the first quarter of 2013. On a GAAP basis, gross margin was 46.8%, compared to 47.5% in the prior quarter and 42.7% in the year-ago period. Operating income was $2.0 million, compared to operating income of $1.3 million in the prior quarter and an operating loss of $9.6 million in the year-ago period. Net income was $1.6 million or $0.07 per diluted share, compared to net income of $0.6 million or $0.02 per diluted share in the prior quarter and a net loss of $5.6 million or $0.24 per share in the first quarter of 2013.
On a non-GAAP basis, which excludes amortization of acquired intangible assets, gross margin was 48.1% compared to 48.9% in the prior quarter and 45.4% in the year-ago period. Non-GAAP operating income for the first quarter was $2.8 million, compared to operating income of $2.1 million in the prior quarter and an operating loss of $8.7 million in the first quarter of 2013. Non-GAAP net income, which also adjusts for the income tax effect of non-GAAP adjustments, was $2.1 million or $0.09 per diluted share, compared to net income of $1.0 million or $0.04 per share in the prior quarter and a net loss of $5.0 million or $0.22 per share in the first quarter of 2013.
Balance Sheet Strength
At March 29, 2014, Nanometrics had $88.0 million in cash, cash equivalents and marketable securities and $147.6 million in working capital. Stockholders' equity, excluding intangible assets, was $194.3 million, or $8.14 per share based on 23.9 million shares outstanding at quarter-end.
Business Outlook
Management expects total revenues for the second quarter of 2014 to be in the range of $47 to $51 million, with GAAP gross margin in the range of 46% to 49% and non-GAAP gross margin in the range of 47% to 50%. Management expects second quarter operating expenses to increase between $0.1 and $0.9 million from the first quarter, with GAAP earnings to range from ($0.04) to $0.06 per share and non-GAAP earnings to range from ($0.03) to $0.08 per share.
Conference Call Details
A conference call to discuss first quarter 2014 results will be held today at 4:30 p.m. EDT (1:30 p.m. PDT). To participate in the conference call, the dial-in numbers are (877) 374-4041 for domestic callers and (253) 237-1156 for international callers. A live and recorded webcast and supplemental financial information will be made available on the investor page of the Nanometrics website at www.nanometrics.com .
Use of Non-GAAP Financial Information
Financial results such as non-GAAP gross profit, gross margin, operating income, net income, and net income per share, which exclude certain expenses, charges and special items, were not prepared in accordance with U.S. Generally Accepted Accounting Principles (GAAP). Management uses non-GAAP financial results, which exclude acquisition-related expenses such as amortization of acquired intangibles and transaction costs, asset impairments including certain excess and obsolete inventory charges related to a discontinued product line, restructuring charges, and other unusual and infrequent items to evaluate the company's ongoing performance and to enable comparison to other periods that did not include these unusual and infrequent items. The company believes the presentation of non-GAAP results is useful to investors for analyzing ongoing business trends, comparing performance to prior periods, and enhancing the investor's ability to view the company's results from management's perspective. A table presenting a reconciliation of GAAP results to non-GAAP results is included at the end of this press release and is available on the investor page of the Nanometrics website at www.nanometrics.com .
About Nanometrics
Nanometrics is a leading provider of advanced, high-performance process control metrology and inspection systems used primarily in the fabrication of semiconductors and other solid-state devices, such as data storage components and discretes including high-brightness LEDs and power management components. Nanometrics' automated and integrated metrology systems measure critical dimensions, device structures, overlay registration, topography and various thin film properties, including film thickness as well as optical, electrical and material properties. The company's process control solutions are deployed throughout the fabrication process, from front-end-of-line substrate manufacturing, to high-volume production of semiconductors and other devices, to advanced wafer-scale packaging applications. Nanometrics' systems enable advanced process control for device manufacturers, providing improved device yield at reduced manufacturing cycle time, supporting the accelerated product life cycles in the semiconductor market. The company maintains its headquarters in Milpitas, California, with sales and service offices worldwide. Nanometrics is traded on NASDAQ Global Select Market under the symbol NANO. Nanometrics' website is http://www.nanometrics.com .
Forward Looking Statements
The statements in this press release under the caption "Business Outlook," and in Dr. Stultz's quote regarding the company's expectations as to revenue, performance and financial results, are forward-looking statements. Although Nanometrics believes that the expectations reflected in the forward-looking statements are reasonable, actual results could differ materially from these expectations due to a variety of factors, including timing of product acceptance, economic conditions, levels of industry spending, shifts in the timing of customer orders and product shipments, market adoption rates, changes in product mix, and changes in operating expenses. For additional information and considerations regarding the risks faced by Nanometrics, see its annual report on Form 10-K for the year ended December 28, 2013, as filed with the Securities and Exchange Commission on March 7, 2014, including under the caption "Risk Factors," as well as other periodic reports filed with the SEC from time to time. Nanometrics disclaims any obligation to update information contained in any forward-looking statement.
| NANOMETRICS INCORPORATED | ||
| CONSOLIDATED BALANCE SHEETS | ||
| (In thousands) | ||
| (Unaudited) | ||
| March 29, | December 28, | |
| 2014 | 2013 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $ 38,833 | $ 44,765 |
| Marketable securities | 49,204 | 48,097 |
| Accounts receivable, net | 32,417 | 31,436 |
| Inventories | 37,855 | 34,520 |
| Inventories-delivered systems | 2,249 | 6,901 |
| Prepaid expenses and other | 8,972 | 10,519 |
| Deferred income tax assets | 14,008 | 14,516 |
| Total current assets | 183,538 | 190,754 |
| Property, plant and equipment, net | 47,131 | 47,439 |
| Goodwill | 11,865 | 11,743 |
| Intangible assets, net | 7,139 | 7,864 |
| Deferred income tax assets | 4,345 | 4,338 |
| Other assets | 699 | 696 |
| Total assets | $ 254,717 | $ 262,834 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $ 7,409 | $ 10,661 |
| Accrued payroll and related expenses | 8,200 | 7,853 |
| Deferred revenue | 11,542 | 21,749 |
| Other current liabilities | 8,185 | 7,936 |
| Income taxes payable | 557 | 758 |
| Total current liabilities | 35,893 | 48,957 |
| Deferred revenue | 3,310 | 3,718 |
| Income taxes payable | 599 | 1,171 |
| Other long-term liabilities | 1,645 | 1,615 |
| Total liabilities | 41,447 | 55,461 |
| Stockholders' equity: | ||
| Common stock | 24 | 24 |
| Additional paid-in capital | 248,824 | 244,733 |
| Accumulated deficit | (36,401) | (37,996) |
| Accumulated other comprehensive income | 823 | 612 |
| Total stockholders' equity | 213,270 | 207,373 |
| Total liabilities and stockholders' equity | $ 254,717 | $ 262,834 |
| NANOMETRICS INCORPORATED | ||
| CONSOLIDATED STATEMENTS OF OPERATIONS | ||
| (In thousands except per share amounts) | ||
| (Unaudited) | ||
| Three Months Ended | ||
| March 29, | March 30, | |
| 2014 | 2013 | |
| Net revenues: | ||
| Products | $ 43,280 | $ 13,079 |
| Service | 8,296 | 11,473 |
| Total net revenues | 51,576 | 24,552 |
| Costs of net revenues: | ||
| Cost of products | 21,639 | 7,960 |
| Cost of service | 5,114 | 5,448 |
| Amortization of intangible assets | 674 | 658 |
| Total costs of net revenues | 27,427 | 14,066 |
| Gross profit | 24,149 | 10,486 |
| Operating expenses: | ||
| Research and development | 8,314 | 7,447 |
| Selling | 7,373 | 6,932 |
| General and administrative | 6,338 | 5,512 |
| Amortization of intangible assets | 108 | 198 |
| Total operating expenses | 22,133 | 20,089 |
| Income (loss) from operations | 2,016 | (9,603) |
| Other income (expense): | ||
| Interest income | 14 | 25 |
| Interest expense | (100) | (226) |
| Other expense, net | 252 | 40 |
| Total other income (expense), net | 166 | (161) |
| Income (loss) before income taxes | 2,182 | (9,764) |
| Provision for (benefit from) income taxes | 587 | (4,182) |
| Net income (loss) | $ 1,595 | $ (5,582) |
| Net income (loss) per share: | ||
| Basic | $ 0.07 | $ (0.24) |
| Diluted | $ 0.07 | $ (0.24) |
| Shares used in per share calculation: | ||
| Basic | 23,711 | 23,341 |
| Diluted | 24,159 | 23,341 |
| NANOMETRICS INCORPORATED | ||
| CONSOLIDATED STATEMENTS OF CASH FLOWS | ||
| (In thousands) | ||
| (Unaudited) | ||
| Three Months Ended | ||
| March 29, | March 30, | |
| 2014 | 2013 | |
| Cash flows from operating activities: | ||
| Net income (loss) | $ 1,595 | $ (5,582) |
| Reconciliation of net income (loss) to net cash used in operating activities: | ||
| Depreciation and amortization | 2,429 | 2,108 |
| Stock-based compensation | 1,634 | 1,457 |
| Excess tax benefit from equity awards | -- | 367 |
| Loss on disposal of fixed assets | -- | 12 |
| Inventory write down | 669 | 1,321 |
| Deferred income taxes | 519 | (4,065) |
| Changes in fair value of contingent consideration | (5) | 389 |
| Changes in assets and liabilities: | ||
| Accounts receivable | (967) | 1,268 |
| Inventories | (3,142) | (5,631) |
| Inventories-delivered systems | 4,652 | 750 |
| Prepaid expenses and other | 1,845 | 592 |
| Accounts payable, accrued and other liabilities | (2,536) | (351) |
| Deferred revenue | (10,619) | (796) |
| Income taxes payable | (766) | (360) |
| Net cash used in operations | (4,692) | (8,521) |
| Cash flows from investing activities: | ||
| Maturities of marketable securities | 7,000 | 10,111 |
| Purchases of marketable securities | (8,410) | (11,292) |
| Purchase of property, plant and equipment | (2,193) | (997) |
| Net cash used in investing activities | (3,603) | (2,178) |
| Cash flows from financing activities: | ||
| Payments of contingent consideration | (100) | (133) |
| Repayments of debt obligations | -- | (227) |
| Proceeds from sale of shares under employee stock option and purchase plans | 3,115 | 1,598 |
| Excess tax benefit from equity awards | -- | (367) |
| Taxes paid on net issuance of stock awards | (659) | (86) |
| Repurchases of common stock | -- | (5,000) |
| Net cash provided by (used in) financing activities | 2,356 | (4,215) |
| Effect of exchange rate changes on cash and cash equivalents | 7 | (656) |
| Net decrease in cash and cash equivalents | (5,932) | (15,570) |
| Cash and cash equivalents, beginning of period | 44,765 | 62,915 |
| Cash and cash equivalents, end of period | $ 38,833 | $ 47,345 |
| NANOMETRICS INCORPORATED | |||
| RECONCILIATION OF GAAP TO NON-GAAP RESULTS | |||
| (In thousands, except per share amounts) | |||
| (Unaudited) | |||
| Three Months Ended | |||
| Mar 29, | Dec 28, | Mar 30, | |
| 2014 | 2013 | 2013 | |
| Reconciliation of GAAP gross profit to non-GAAP gross profit | |||
| GAAP gross profit | $ 24,149 | $ 21,909 | $ 10,486 |
| Non-GAAP adjustments: | |||
| Amortization of intangible assets | 674 | 670 | 658 |
| Non-GAAP gross profit | $ 24,823 | $ 22,579 | $ 11,144 |
| Reconciliation of GAAP operating income (loss) to non-GAAP operating income (loss) | |||
| GAAP operating income (loss) | $ 2,016 | $ 1,292 | $ (9,603) |
| Non-GAAP adjustments: | |||
| Amortization of intangible assets included in cost of revenues | 674 | 670 | 658 |
| Amortization of intangible assets included in operating expenses | 108 | 113 | 198 |
| Total non-GAAP adjustments to operating income (loss) | 782 | 783 | 856 |
| Non-GAAP operating income (loss) | $ 2,798 | $ 2,075 | $ (8,747) |
| Reconciliation of GAAP net income (loss) to non-GAAP net income (loss) | |||
| GAAP net income (loss) | $ 1,595 | $ 556 | $ (5,582) |
| Non-GAAP adjustments: | |||
| Total non-GAAP adjustments to non-GAAP operating income (loss) | 782 | 783 | 856 |
| Income tax effect of non-GAAP adjustments | (282) | (317) | (306) |
| Non-GAAP net income (loss) | $ 2,095 | $ 1,022 | $ (5,032) |
| GAAP net income (loss) per diluted share | $ 0.07 | $ 0.02 | $ (0.24) |
| Non-GAAP net income (loss) per diluted share | $ 0.09 | $ 0.04 | $ (0.22) |
| Shares used in diluted net income (loss) per share calculation | 24,159 | 23,913 | 23,341 |
Investor Relations Contact: Claire McAdams Headgate Partners LLC 530.265.9899 email: Company Contact: Ronald Kisling, CFO Nanometrics Incorporated 408.545.6143 email:
